THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
109,322,381
Share change
-3,194,040
Total reported value
$859,225,513
Put/Call ratio
18%
Price per share
$7.86
Number of holders
113
Value change
-$17,806,752
Number of buys
80
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2015

As of 30 Jun 2015, THERAPEUTICSMD INC - COM (TXMD) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 109,322,381 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Bank of New York Mellon Corp, FRANKLIN RESOURCES INC, GILDER GAGNON HOWE & CO LLC, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, VANGUARD GROUP INC, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/. This page lists 113 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.